TKNO (Alpha Teknova, Inc.) Stock Financials & Earnings

TKNOAlpha Teknova, Inc.

Mkt Cap$133M

Revenue (TTM)$41M

Net Income (TTM)-$17M

EPS (TTM)-$0.32

Free Cash Flow (TTM)-$10M

Gross Margin33.2%

Op. Margin-41.9%

Net Margin-42.6%

FCF Margin-23.7%

P/S Ratio (TTM)3.3x

P/E Ratio (TTM)—

YoY Rev Growth+7.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$9M	$2M	-$9M
Q2 23	$12M	$5M	-$7M
Q3 23	$8M	$1M	-$9M
Q4 23	$8M	$1M	-$11M
Q1 24	$9M	$2M	-$8M
Q2 24	$10M	$3M	-$5M
Q3 24	$10M	$90K	-$7M
Q4 24	$9M	$2M	-$6M
Q1 25	$10M	$3M	-$5M
Q2 25	$10M	$4M	-$3M
Q3 25	$10M	$3M	-$4M
Q4 25	$10M	$3M	-$5M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$1M	$7M	$2M
Q2 23	$1M	$6M	$2M
Q3 23	$1M	$6M	$2M
Q4 23	$1M	$6M	$2M
Q1 24	$860K	$7M	$2M
Q2 24	$678K	$5M	$1M
Q3 24	$627K	$5M	$2M
Q4 24	$594K	$5M	$2M
Q1 25	$552K	$5M	$2M
Q2 25	$581K	$5M	$2M
Q3 25	$542K	$5M	$2M
Q4 25	$522K	$5M	$2M

Revenue Segments

Quarter	Clinical Solutions	Lab Essentials	Other Product
Q1 23	$2M	$7M	$255K
Q2 23	$4M	$8M	$293K
Q3 23	$597K	$7M	$298K
Q4 23	$879K	$7M	$300K
Q1 24	$2M	$7M	$306K
Q2 24	$2M	$8M	$411K
Q3 24	$2M	$7M	$451K
Q4 24	$2M	$7M	$597K
Q1 25	$1M	$8M	$516K
Q2 25	$2M	$8M	$435K
Q3 25	$2M	$8M	$440K
Q4 25	$3M	$7M	$435K

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$30M	$0	$30M
Q2 23	$24M	$0	$24M
Q3 23	$32M	$0	$32M
Q4 23	$28M	$0	$28M
Q1 24	$22M	$0	$22M
Q2 24	$19M	$0	$19M
Q3 24	$6M	$26M	$32M
Q4 24	$4M	$27M	$30M
Q1 25	$3M	$23M	$26M
Q2 25	$3M	$21M	$24M
Q3 25	$3M	$0	$3M
Q4 25	$6M	$0	$6M

Shares Outstanding

Revenue Per Employee

Revenue / Employee